vimarsana.com
Home
Live Updates
Intra-Cellular Therapies Announces Positive Topline Results
Intra-Cellular Therapies Announces Positive Topline Results
Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features
Lumateperone 42mg was statistically significant on the primary endpoint of symptom reduction on the Montgomery Asberg Depression Rating Scale for each patient population including: -combined major... | March 28, 2023
Related Keywords
Ukraine ,
Juan Sanchez ,
Cameron Radinovic ,
Burns Mcclellan Inc ,
Nasdaq ,
Globenewswire Inc ,
Corporate Communications ,
Exchange Commission ,
Cellular Therapies Inc ,
Montgomery Asberg Depression Rating Scale ,
Global Impression ,
Severity Scale ,
Cellular Therapies ,
About Study ,
Statistical Manual ,
Mental Disorder ,
Young Mania Rating ,
About Mixed Features ,
Bipolar Depression ,
Major Depressive ,
Adverse Reactions ,
Elderly Patients ,
Dementia Related Psychosis ,
Boxed Warning ,
Malignant Syndrome ,
Blood Pressure ,
Private Securities Litigation Reform Act ,
Intra Cellular Therapies ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Lumateperone ,
2mg ,
Gas ,
Statistically ,
Significant ,
N ,
The ,
Primary ,
Ndpoint ,
F ,
Symptom ,
Reduction ,
Ontgomery ,
Osberg ,
Depression ,
Eating ,
Scale ,
Or ,
Peach ,
Patient ,
Opulation Itci Us46116x1019 ,